You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2024

CLINICAL TRIALS PROFILE FOR TOVORAFENIB

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for tovorafenib

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT05465174 ↗	Nivolumab and DAY101 for Treatment of Craniopharyngioma in Children and Young Adults	Not yet recruiting	Bristol-Myers Squibb	Phase 2	2022-09-01	The current study assesses the tolerability and efficacy of combination therapy with PD-1 (nivolumab) and pan-RAF-kinase (DAY101) inhibition for the treatment of children and young adults with craniopharyngioma.
NCT05465174 ↗	Nivolumab and DAY101 for Treatment of Craniopharyngioma in Children and Young Adults	Not yet recruiting	Day One Biopharmaceuticals, Inc.	Phase 2	2022-09-01	The current study assesses the tolerability and efficacy of combination therapy with PD-1 (nivolumab) and pan-RAF-kinase (DAY101) inhibition for the treatment of children and young adults with craniopharyngioma.
NCT05465174 ↗	Nivolumab and DAY101 for Treatment of Craniopharyngioma in Children and Young Adults	Not yet recruiting	Sabine Mueller, MD, PhD	Phase 2	2022-09-01	The current study assesses the tolerability and efficacy of combination therapy with PD-1 (nivolumab) and pan-RAF-kinase (DAY101) inhibition for the treatment of children and young adults with craniopharyngioma.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for tovorafenib

Condition Name

Chart
Table

Condition Name for tovorafenib
Intervention	Trials
Recurrent Craniopharyngioma	1
Recurrent Langerhans Cell Histiocytosis	1
Refractory Langerhans Cell Histiocytosis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for tovorafenib
Intervention	Trials
Histiocytosis	1
Glioma	1
Craniopharyngioma	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for tovorafenib

Trials by Country

Map
Table

Trials by Country for tovorafenib
Location	Trials
United States	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for tovorafenib
Location	Trials
New York	1
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for tovorafenib

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for tovorafenib
Clinical Trial Phase	Trials
Phase 3	1
Phase 2	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for tovorafenib
Clinical Trial Phase	Trials
Not yet recruiting	2
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for tovorafenib

Sponsor Name

Chart
Table

Sponsor Name for tovorafenib
Sponsor	Trials
Day One Biopharmaceuticals, Inc.	2
Bristol-Myers Squibb	1
Sabine Mueller, MD, PhD	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for tovorafenib
Sponsor	Trials
Industry	3
Other	2
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.